We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.49B
AUM Growth
-$343M
Cap. Flow
-$249M
Cap. Flow %
-2.94%
Top 10 Hldgs %
16.07%
Holding
2,271
New
51
Increased
125
Reduced
935
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 17.14%
2 Financials 17.01%
3 Healthcare 12.77%
4 Industrials 11.29%
5 Consumer Discretionary 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAIC
2151
DELISTED
Arlington Asset Investment Corp.
AAIC
$111K ﹤0.01%
10,056
KG
2152
Kestrel Group
KG
$66.9M
$109K ﹤0.01%
840
-817
-49% -$113K
EMCI
2153
DELISTED
EMC INS Group Inc
EMCI
$103K ﹤0.01%
3,800
ATEX icon
2154
Anterix
ATEX
$1.73B
$101K ﹤0.01%
3,369
CIVI
2155
DELISTED
Civitas Solutions, Inc.
CIVI
$99K ﹤0.01%
6,456
RMTI icon
2156
Rockwell Medical
RMTI
$29.8M
$98K ﹤0.01%
171
SHOE
2157
Shoe Station Group
SHOE
$419M
$98K ﹤0.01%
8,228
WMC
2158
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$98K ﹤0.01%
1,009
-1,084
-52% -$103K
ECOM
2159
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$95K ﹤0.01%
10,403
DMRC icon
2160
Digimarc Corp
DMRC
$168M
$94K ﹤0.01%
3,943
RETA
2161
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$92K ﹤0.01%
4,477
AGEN
2162
Agenus
AGEN
$311M
$90K ﹤0.01%
970
-971
-50% -$86.3K
JCAP
2163
DELISTED
Jernigan Capital, Inc.
JCAP
$88K ﹤0.01%
4,880
GSAT icon
2164
Globalstar
GSAT
$10.8B
$86K ﹤0.01%
8,326
-9,471
-53% -$141K
ELGX
2165
DELISTED
Endologix Inc
ELGX
$77K ﹤0.01%
1,810
-2,596
-59% -$111K
NVTA
2166
DELISTED
Invitae Corporation
NVTA
$75K ﹤0.01%
15,995
DX
2167
Dynex Capital
DX
$3.22B
$68K ﹤0.01%
3,394
-5,413
-61% -$106K
DAKT icon
2168
Daktronics
DAKT
$996M
$62K ﹤0.01%
7,069
-11,444
-62% -$105K
CLDX icon
2169
Celldex Therapeutics
CLDX
$3.52B
$55K ﹤0.01%
1,561
-2,822
-64% -$109K
OPCH icon
2170
Option Care Health
OPCH
$3.57B
$50K ﹤0.01%
5,045
-9,906
-66% -$115K
CALX icon
2171
Calix
CALX
$2.51B
$46K ﹤0.01%
6,678
-14,741
-69% -$95.2K
AXTI icon
2172
AXT Inc
AXTI
$5.14B
$43K ﹤0.01%
5,921
-13,175
-69% -$107K
DS
2173
DELISTED
Drive Shack Inc.
DS
$42K ﹤0.01%
8,736
-21,822
-71% -$111K
EVC icon
2174
Entravision Communication
EVC
$832M
$41K ﹤0.01%
8,774
-20,871
-70% -$135K
CLD
2175
DELISTED
Cloud Peak Energy Inc
CLD
$36K ﹤0.01%
12,337
-31,091
-72% -$129K

Similar funds

MetLife Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, MetLife Investment Management held 2,271 positions worth $8.49B, down 3.9% from $8.84B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management's Q1 2018 filing shows 51 new, 125 increased, 935 reduced and 90 closed positions. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M. The largest sale was Bank of New York Mellon, an estimated $17.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2018 buy was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $25.3M increase.
  • MetLife Investment Management's biggest Q1 2018 reduction was Apple, cutting an estimated $10.6M.
  • MetLife Investment Management fully exited Bank of New York Mellon in Q1 2018, selling an estimated $17.1M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $8.49B portfolio in Q1 2018.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q1 2018.
  • MetLife Investment Management's portfolio value fell 3.9% quarter-over-quarter to $8.49B.

Based on MetLife Investment Management's 13F filing for Q1 2018, filed 15 May 2018.